COLUMN GROUP III-A, LP
SEC CIK 1668085 · EDGAR
BoughtSold
Most active insiders at TNYA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | COLUMN GROUP III-A, LP | 10% | — | $3.54M |
| 2 | TCG Opportunity III GP, LLC | 10% | — | $2.37M |
| 3 | Ali Faraz | CEO, Dir | — | $32.1K |
| 4 | Tingley Whittemore | Chief Medical Off | — | $14.9K |
| 5 | Higa Tomohiro | SVP, Fin | — | $5,216 |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-02-24 | 2026-02-20+ | TNYA | Tenaya Therapeutics, Inc. | COLUMN GROUP III-A, LP | 10% | S - Sale | $0.6063 | -829.7K | 1.96M | -30% | -$503.1K |
| MI | 2026-02-12 | 2026-02-10+ | TNYA | Tenaya Therapeutics, Inc. | COLUMN GROUP III-A, LP | 10% | S - Sale | $0.6909 | -4.40M | 4.80M | -48% | -$3.04M |
| MAI | 2024-04-17 | 2024-04-04 | SRZN | Surrozen, Inc./DE | COLUMN GROUP III-A, LP | 10% | P - Purchase | $15.50 | +193.5K | 327.0K | +145% | +$3.00M |
| I | 2024-02-14 | 2024-02-12 | TNYA | Tenaya Therapeutics, Inc. | COLUMN GROUP III-A, LP | 10% | P - Purchase | $4.50 | +2.22M | 13.60M | +20% | +$10.00M |
| I | 2023-02-10 | 2023-02-08 | TNYA | Tenaya Therapeutics, Inc. | COLUMN GROUP III-A, LP | 10% | P - Purchase | $2.60 | +1.50M | 11.37M | +15% | +$3.90M |
Purchase Sale Sale after option exercise All abbreviations